PLOS ONE (journal)

The arrestin-GPCR connection

Understanding details of how arrestins deactivate signaling by G-protein coupled receptors is key to the design of new therapeutics aimed at these cellular “inboxes” that are targeted by up to half of all pharmaceuticals.

Community-driven health efforts saving lives in Lwala

Eleven years after two Vanderbilt University medical students established a health care organization in an impoverished area of Kenya, the death rate for children under 5 years old has been cut in half, according to researchers from Kenya and the Vanderbilt Institute for Global Health (VIGH).

Mother knows best

The first demonstration of bacterial DNA in mammalian fetal intestinal tissue suggests that the mother’s microbiome moves into the fetal intestine.

New method to thwart false positives in CT-lung cancer screening

A team of investigators led by Fabien Maldonado, MD, associate professor of Medicine at Vanderbilt, and Tobias Peikert, MD, assistant professor of Medicine at Mayo Clinic, Rochester, Minnesota, has identified a new technology to address false positives in CT-based lung cancer screening. The study was published in the latest issue of PLOS One.

Number of minority trainees on rise, but not minority faculty

Vanderbilt investigators examined the entire training pathway of potential biomedical research faculty and found two key points of loss: during undergraduate education and in transition from postdoctoral fellowship to tenure-track faculty.

four african american women posing for a photo outside. some are overweight.

Rising obesity rates in South leading to rapid increase in diabetes

Rising obesity rates in several Southern states are leading to a rapid increase in new cases of diabetes among both black and white adults. A new study helmed by investigators at the University of Texas Health Science Center and Vanderbilt University Medical Center (VUMC) found the risk of diabetes is double for black patients.

1 2 3 4 5